Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 261 (RNA5SP261), also known as RN5S261, is annotated as a pseudogene related to the gene encoding 5S ribosomal RNA. Pseudogenes are disabled copies of functional genes and are typically non-coding; they generally do not produce functional RNA or protein products, although a subset are transcribed and may have regulatory roles[2][4]. 5S ribosomal RNA is a component of the ribosome, where it contributes to ribosomal structure and function[1][3][5]; RN5S261 is a pseudogene and does not encode functional 5S rRNA, nor is it known to be translated or involved directly in ribosome function. Pseudogenes like RNA5SP261 are not conventional drug targets (such as enzymes, transporters, or receptors), and there is no evidence that therapeutics are designed to modulate their activity[2][4]. However, some pseudogenes can be expressed and act as non-coding RNAs that regulate their parent gene or participate in regulatory networks (e.g., as competing endogenous RNAs, or ceRNAs)[2][4]. In some cancers, altered expression of certain pseudogenes may serve as a biomarker or play a regulatory role, but RNA5SP261 itself has not been specifically reported in the disease or drug interaction literature. There is nothing to suggest that RNA, 5S ribosomal pseudogene 261 represents a validated or conventional therapeutic target. Summary of issues: - This entity is a **pseudogene**, not a functional receptor, enzyme, transporter, or other drug target. - No evidence suggests its direct therapeutic targeting, biomarker utility, or drug interaction. - Its alternate names are variations of its systematic pseudogene annotation and should not be considered as aliases for a functional target. - The entry is, for most research or clinical purposes, non-actionable and/or incorrect as a pharmacological target. If you require information about the functional 5S ribosomal RNA, see 5S rRNA (component of the ribosome)[1][3][5]. If you are seeking pseudogene biology or pseudogene-based markers in cancer, consult comprehensive genomics and cancer biomarker studies[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 261 (RNA5SP261).